Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 4.47735387 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.44415866 |
3 | negative regulation of cell killing (GO:0031342) | 4.44415866 |
4 | low-density lipoprotein particle clearance (GO:0034383) | 4.41600260 |
5 | hepatocyte apoptotic process (GO:0097284) | 4.33788983 |
6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27209209 |
7 | regulation of cholesterol storage (GO:0010885) | 3.79987707 |
8 | neutrophil activation involved in immune response (GO:0002283) | 3.64735221 |
9 | positive regulation of receptor recycling (GO:0001921) | 3.59052782 |
10 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.58956375 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.58180961 |
12 | positive regulation of granulocyte differentiation (GO:0030854) | 3.48855431 |
13 | regulation of platelet aggregation (GO:0090330) | 3.47271062 |
14 | positive regulation of interferon-alpha production (GO:0032727) | 3.43874149 |
15 | negative regulation of lipid storage (GO:0010888) | 3.41287563 |
16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.40421848 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.40315683 |
18 | macrophage activation (GO:0042116) | 3.35503394 |
19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.31408728 |
20 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.29740446 |
21 | modulation by symbiont of host defense response (GO:0052031) | 3.29196259 |
22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.29196259 |
23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.29196259 |
24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.29196259 |
25 | modulation by symbiont of host immune response (GO:0052553) | 3.29196259 |
26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.29196259 |
27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28630102 |
28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28630102 |
29 | regulation of interferon-alpha production (GO:0032647) | 3.27247379 |
30 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.25378624 |
31 | plasma lipoprotein particle clearance (GO:0034381) | 3.17283531 |
32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16013421 |
33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.13457877 |
34 | detection of external biotic stimulus (GO:0098581) | 3.12531815 |
35 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.11140761 |
36 | response to peptidoglycan (GO:0032494) | 3.08092032 |
37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07043912 |
38 | regulation of necroptotic process (GO:0060544) | 3.06828075 |
39 | histone H3-K36 demethylation (GO:0070544) | 3.06081694 |
40 | negative T cell selection (GO:0043383) | 3.05054272 |
41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04099211 |
42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03753984 |
43 | positive regulation of p38MAPK cascade (GO:1900745) | 3.03603047 |
44 | detection of bacterium (GO:0016045) | 3.02663071 |
45 | growth hormone receptor signaling pathway (GO:0060396) | 3.00857154 |
46 | B cell receptor signaling pathway (GO:0050853) | 3.00183037 |
47 | valine metabolic process (GO:0006573) | 2.99519996 |
48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97484621 |
49 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.96185794 |
50 | myeloid cell development (GO:0061515) | 2.94840853 |
51 | thrombin receptor signaling pathway (GO:0070493) | 2.94056850 |
52 | respiratory burst (GO:0045730) | 2.93757281 |
53 | myeloid leukocyte mediated immunity (GO:0002444) | 2.93267003 |
54 | protein K11-linked deubiquitination (GO:0035871) | 2.93183310 |
55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92062812 |
56 | positive T cell selection (GO:0043368) | 2.91987286 |
57 | negative thymic T cell selection (GO:0045060) | 2.91728202 |
58 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.90220684 |
59 | positive regulation of interferon-beta production (GO:0032728) | 2.87899841 |
60 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.87480995 |
61 | myeloid cell activation involved in immune response (GO:0002275) | 2.86681175 |
62 | negative regulation of interleukin-12 production (GO:0032695) | 2.86026698 |
63 | erythrocyte development (GO:0048821) | 2.84227338 |
64 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.83922951 |
65 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82864575 |
66 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82864575 |
67 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.81764379 |
68 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81119471 |
69 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.80968924 |
70 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.80968924 |
71 | leukocyte aggregation (GO:0070486) | 2.79930723 |
72 | cysteine metabolic process (GO:0006534) | 2.78454597 |
73 | regulation of mast cell degranulation (GO:0043304) | 2.77299668 |
74 | megakaryocyte development (GO:0035855) | 2.76680571 |
75 | regulation of receptor recycling (GO:0001919) | 2.76463734 |
76 | natural killer cell mediated immunity (GO:0002228) | 2.76311725 |
77 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.76311725 |
78 | macroautophagy (GO:0016236) | 2.76287944 |
79 | cellular response to ethanol (GO:0071361) | 2.74485704 |
80 | positive regulation of B cell differentiation (GO:0045579) | 2.73405862 |
81 | granulocyte activation (GO:0036230) | 2.71615361 |
82 | sequestering of metal ion (GO:0051238) | 2.71394718 |
83 | positive regulation of lipid storage (GO:0010884) | 2.70543379 |
84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.69645284 |
85 | regulation of mast cell activation (GO:0033003) | 2.68777182 |
86 | positive thymic T cell selection (GO:0045059) | 2.68644725 |
87 | NIK/NF-kappaB signaling (GO:0038061) | 2.68255011 |
88 | cytokine secretion (GO:0050663) | 2.67888537 |
89 | neutrophil activation (GO:0042119) | 2.67755862 |
90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.66985263 |
91 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.66382393 |
92 | hemoglobin metabolic process (GO:0020027) | 2.65576645 |
93 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.65274769 |
94 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.64888603 |
95 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.64552666 |
96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64518940 |
97 | urea metabolic process (GO:0019627) | 2.64275418 |
98 | urea cycle (GO:0000050) | 2.64275418 |
99 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.64040568 |
100 | detection of biotic stimulus (GO:0009595) | 2.63768882 |
101 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.63216528 |
102 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.63216528 |
103 | dendritic cell migration (GO:0036336) | 2.62506744 |
104 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.61637989 |
105 | regulation of mitochondrial depolarization (GO:0051900) | 2.60759121 |
106 | histone mRNA catabolic process (GO:0071044) | 2.60364791 |
107 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60359878 |
108 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.60335421 |
109 | oxygen transport (GO:0015671) | 2.59659756 |
110 | T cell migration (GO:0072678) | 2.59424114 |
111 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57757864 |
112 | reactive oxygen species biosynthetic process (GO:1903409) | 2.57728647 |
113 | regulation of regulatory T cell differentiation (GO:0045589) | 2.56983768 |
114 | complement activation, alternative pathway (GO:0006957) | 2.56980005 |
115 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.56929025 |
116 | cellular extravasation (GO:0045123) | 2.56879201 |
117 | regulation of platelet activation (GO:0010543) | 2.55860733 |
118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.54661792 |
119 | phospholipid homeostasis (GO:0055091) | 2.54258319 |
120 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.54143255 |
121 | protein carboxylation (GO:0018214) | 2.54143255 |
122 | macrophage activation involved in immune response (GO:0002281) | 2.52762837 |
123 | neutrophil mediated immunity (GO:0002446) | 2.50782291 |
124 | cellular response to growth hormone stimulus (GO:0071378) | 2.50293988 |
125 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.49619432 |
126 | regulation of sequestering of triglyceride (GO:0010889) | 2.49015654 |
127 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.48744200 |
128 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.48150957 |
129 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.46735558 |
130 | positive regulation of response to oxidative stress (GO:1902884) | 2.46735558 |
131 | negative regulation of B cell proliferation (GO:0030889) | 2.46071050 |
132 | regulation of B cell differentiation (GO:0045577) | 2.45299183 |
133 | activated T cell proliferation (GO:0050798) | 2.45220033 |
134 | protein targeting to Golgi (GO:0000042) | 2.44674493 |
135 | regulation of lipid storage (GO:0010883) | 2.44364788 |
136 | response to host immune response (GO:0052572) | 2.44204973 |
137 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.44204973 |
138 | regulation of antigen processing and presentation (GO:0002577) | 2.44140556 |
139 | leukocyte mediated cytotoxicity (GO:0001909) | 2.43431353 |
140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.43082673 |
141 | protein-lipid complex assembly (GO:0065005) | 2.40917327 |
142 | plasma lipoprotein particle assembly (GO:0034377) | 2.40870144 |
143 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.39081274 |
144 | immunoglobulin mediated immune response (GO:0016064) | 2.36667400 |
145 | phospholipid efflux (GO:0033700) | 2.36190633 |
146 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.35562530 |
147 | positive regulation of mast cell activation (GO:0033005) | 2.34713582 |
148 | nitrogen cycle metabolic process (GO:0071941) | 2.34243040 |
149 | detection of other organism (GO:0098543) | 2.33905247 |
150 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.33381280 |
151 | regulation of RIG-I signaling pathway (GO:0039535) | 2.32402813 |
152 | acute-phase response (GO:0006953) | 2.32126772 |
153 | chronic inflammatory response (GO:0002544) | 2.31758966 |
154 | positive regulation of interleukin-12 production (GO:0032735) | 2.31600025 |
155 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.30786021 |
156 | detection of molecule of bacterial origin (GO:0032490) | 2.29461333 |
157 | T-helper 1 type immune response (GO:0042088) | 2.28551111 |
158 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.28211396 |
159 | regulation of triglyceride catabolic process (GO:0010896) | 2.27437110 |
160 | response to muramyl dipeptide (GO:0032495) | 2.25363341 |
161 | response to host (GO:0075136) | 2.23882327 |
162 | response to host defenses (GO:0052200) | 2.23882327 |
163 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.23882327 |
164 | positive regulation of cholesterol transport (GO:0032376) | 2.23807340 |
165 | positive regulation of sterol transport (GO:0032373) | 2.23807340 |
166 | positive regulation of leukocyte degranulation (GO:0043302) | 2.23714479 |
167 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.22676757 |
168 | regulation of interferon-beta production (GO:0032648) | 2.22486374 |
169 | Golgi transport vesicle coating (GO:0048200) | 2.22308268 |
170 | COPI coating of Golgi vesicle (GO:0048205) | 2.22308268 |
171 | indolalkylamine catabolic process (GO:0046218) | 2.21528195 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52810447 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.12571295 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.09130641 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73168422 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15932293 |
6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.12550647 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.03800421 |
8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.96695734 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.96218378 |
10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85454179 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.85130055 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84784090 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77401895 |
14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74334792 |
15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.68571649 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64832458 |
17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.63751916 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59097714 |
19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46546695 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.44191062 |
21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37561740 |
22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30729923 |
23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.29543546 |
24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.14657511 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12208188 |
26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.08441034 |
27 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06566623 |
28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05937678 |
29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01830981 |
30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00457035 |
31 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.98934971 |
32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.93909418 |
33 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.86087398 |
34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78654260 |
35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76122872 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74424964 |
37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66207244 |
38 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.64291306 |
39 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57086070 |
40 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56968403 |
41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54588173 |
42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48717377 |
43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47177491 |
44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45994380 |
45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42180952 |
46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40557469 |
47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38466670 |
48 | MYB_26560356_Chip-Seq_TH2_Human | 1.37991984 |
49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37515628 |
50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37101543 |
51 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34967320 |
52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34927635 |
53 | * MAF_26560356_Chip-Seq_TH1_Human | 1.32575149 |
54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29395119 |
55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27928963 |
56 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25817963 |
57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25660053 |
58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25052311 |
59 | * MYB_26560356_Chip-Seq_TH1_Human | 1.24790108 |
60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21551132 |
61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19716695 |
62 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19612437 |
63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18264965 |
64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18014667 |
65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17017278 |
66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15761528 |
67 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.14944624 |
68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13798322 |
69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13262415 |
70 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13119041 |
71 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12635411 |
72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11507699 |
73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11418840 |
74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10610174 |
75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08729235 |
76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08460582 |
77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07623805 |
78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07036412 |
79 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05829199 |
80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05335353 |
81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05121656 |
82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04968219 |
83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04729060 |
84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03947411 |
85 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02884753 |
86 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02884753 |
87 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.02707592 |
88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01803696 |
89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01728056 |
90 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01722695 |
91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01679653 |
92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01464286 |
93 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99975358 |
94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99477902 |
95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99013409 |
96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97395710 |
97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97323703 |
98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96238079 |
99 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96185467 |
100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96046570 |
101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95649536 |
102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95054558 |
103 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.93728250 |
104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92793649 |
105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92484507 |
106 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92214748 |
107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90795033 |
108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90495295 |
109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90320580 |
110 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90048725 |
111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89689558 |
112 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.88401727 |
113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87194697 |
114 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86224199 |
115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85232943 |
116 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84653857 |
117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84303197 |
118 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84276344 |
119 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84076872 |
120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84045873 |
121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83878234 |
122 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83475702 |
123 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83402246 |
124 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83245084 |
125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.82921337 |
126 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82191121 |
127 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80873082 |
128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80519722 |
129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79218129 |
130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79218129 |
131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78586202 |
132 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78475139 |
133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78356941 |
134 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.77308703 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 2.86302205 |
2 | MP0003436_decreased_susceptibility_to | 2.84775031 |
3 | MP0002138_abnormal_hepatobiliary_system | 2.68565103 |
4 | MP0002139_abnormal_hepatobiliary_system | 2.67417183 |
5 | MP0003303_peritoneal_inflammation | 2.57149282 |
6 | MP0009785_altered_susceptibility_to | 2.54869425 |
7 | MP0009840_abnormal_foam_cell | 2.53352212 |
8 | MP0003191_abnormal_cellular_cholesterol | 2.22757350 |
9 | MP0005058_abnormal_lysosome_morphology | 2.17291960 |
10 | MP0003828_pulmonary_edema | 2.17252809 |
11 | MP0000685_abnormal_immune_system | 2.15797275 |
12 | MP0005365_abnormal_bile_salt | 2.14636727 |
13 | MP0002419_abnormal_innate_immunity | 2.12791497 |
14 | MP0005360_urolithiasis | 2.08621693 |
15 | MP0003724_increased_susceptibility_to | 1.99563240 |
16 | MP0003763_abnormal_thymus_physiology | 1.94886767 |
17 | MP0005000_abnormal_immune_tolerance | 1.92400756 |
18 | MP0000465_gastrointestinal_hemorrhage | 1.90166620 |
19 | MP0005085_abnormal_gallbladder_physiolo | 1.88231889 |
20 | MP0005025_abnormal_response_to | 1.86585804 |
21 | MP0002148_abnormal_hypersensitivity_rea | 1.86393851 |
22 | MP0006082_CNS_inflammation | 1.84332498 |
23 | MP0005387_immune_system_phenotype | 1.83222816 |
24 | MP0001790_abnormal_immune_system | 1.83222816 |
25 | MP0003656_abnormal_erythrocyte_physiolo | 1.83220466 |
26 | MP0003300_gastrointestinal_ulcer | 1.81132700 |
27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.75494453 |
28 | MP0005083_abnormal_biliary_tract | 1.74898561 |
29 | MP0000015_abnormal_ear_pigmentation | 1.74611809 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.72575971 |
31 | MP0004947_skin_inflammation | 1.71710602 |
32 | MP0004883_abnormal_blood_vessel | 1.69021475 |
33 | MP0003252_abnormal_bile_duct | 1.65332938 |
34 | MP0004484_altered_response_of | 1.64895353 |
35 | MP0001533_abnormal_skeleton_physiology | 1.62348038 |
36 | MP0002452_abnormal_antigen_presenting | 1.60160993 |
37 | MP0002332_abnormal_exercise_endurance | 1.59237281 |
38 | MP0002254_reproductive_system_inflammat | 1.54806313 |
39 | MP0005671_abnormal_response_to | 1.53163456 |
40 | MP0009764_decreased_sensitivity_to | 1.53002236 |
41 | MP0008004_abnormal_stomach_pH | 1.52005625 |
42 | MP0003806_abnormal_nucleotide_metabolis | 1.51661924 |
43 | MP0001845_abnormal_inflammatory_respons | 1.51114202 |
44 | MP0001800_abnormal_humoral_immune | 1.50647939 |
45 | MP0004510_myositis | 1.50436732 |
46 | MP0002723_abnormal_immune_serum | 1.48676302 |
47 | MP0010352_gastrointestinal_tract_polyps | 1.46781354 |
48 | MP0004381_abnormal_hair_follicle | 1.45031000 |
49 | MP0000609_abnormal_liver_physiology | 1.44877620 |
50 | MP0005464_abnormal_platelet_physiology | 1.42883870 |
51 | MP0002877_abnormal_melanocyte_morpholog | 1.41339933 |
52 | MP0001666_abnormal_nutrient_absorption | 1.41167363 |
53 | MP0004147_increased_porphyrin_level | 1.41104277 |
54 | MP0008469_abnormal_protein_level | 1.40961281 |
55 | MP0010329_abnormal_lipoprotein_level | 1.40379651 |
56 | MP0002722_abnormal_immune_system | 1.38236674 |
57 | MP0008057_abnormal_DNA_replication | 1.37841842 |
58 | MP0002405_respiratory_system_inflammati | 1.36012964 |
59 | MP0001819_abnormal_immune_cell | 1.35972892 |
60 | MP0003566_abnormal_cell_adhesion | 1.35748567 |
61 | MP0002166_altered_tumor_susceptibility | 1.33935770 |
62 | MP0002420_abnormal_adaptive_immunity | 1.33073608 |
63 | MP0005076_abnormal_cell_differentiation | 1.29522905 |
64 | MP0005310_abnormal_salivary_gland | 1.29203349 |
65 | MP0005174_abnormal_tail_pigmentation | 1.28941272 |
66 | MP0003866_abnormal_defecation | 1.28791628 |
67 | MP0005164_abnormal_response_to | 1.27878204 |
68 | MP0001851_eye_inflammation | 1.27265941 |
69 | MP0003448_altered_tumor_morphology | 1.23151969 |
70 | MP0003091_abnormal_cell_migration | 1.21973790 |
71 | MP0004808_abnormal_hematopoietic_stem | 1.21750862 |
72 | MP0000343_altered_response_to | 1.21400513 |
73 | MP0001853_heart_inflammation | 1.19945068 |
74 | MP0004130_abnormal_muscle_cell | 1.18388920 |
75 | MP0002006_tumorigenesis | 1.16299221 |
76 | MP0010307_abnormal_tumor_latency | 1.15888801 |
77 | MP0010155_abnormal_intestine_physiology | 1.15872252 |
78 | MP0004185_abnormal_adipocyte_glucose | 1.15743698 |
79 | MP0003186_abnormal_redox_activity | 1.15576865 |
80 | MP0004782_abnormal_surfactant_physiolog | 1.13754793 |
81 | MP0000858_altered_metastatic_potential | 1.13646272 |
82 | MP0009278_abnormal_bone_marrow | 1.13483080 |
83 | MP0005319_abnormal_enzyme/_coenzyme | 1.13162108 |
84 | MP0004019_abnormal_vitamin_homeostasis | 1.10219135 |
85 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10157515 |
86 | MP0003453_abnormal_keratinocyte_physiol | 1.08626086 |
87 | MP0000703_abnormal_thymus_morphology | 1.07262368 |
88 | MP0003195_calcinosis | 1.07112861 |
89 | MP0000569_abnormal_digit_pigmentation | 1.07032652 |
90 | MP0009763_increased_sensitivity_to | 1.07002790 |
91 | MP0009333_abnormal_splenocyte_physiolog | 1.03147351 |
92 | MP0002118_abnormal_lipid_homeostasis | 1.01013264 |
93 | MP0003172_abnormal_lysosome_physiology | 1.00645102 |
94 | MP0001873_stomach_inflammation | 0.99589789 |
95 | MP0009643_abnormal_urine_homeostasis | 0.97952577 |
96 | MP0005332_abnormal_amino_acid | 0.97917826 |
97 | MP0005075_abnormal_melanosome_morpholog | 0.97594445 |
98 | MP0000249_abnormal_blood_vessel | 0.96674494 |
99 | MP0000604_amyloidosis | 0.96114073 |
100 | MP0000716_abnormal_immune_system | 0.96046263 |
101 | MP0005451_abnormal_body_composition | 0.95203003 |
102 | MP0009765_abnormal_xenobiotic_induced | 0.93812296 |
103 | MP0001545_abnormal_hematopoietic_system | 0.93310304 |
104 | MP0005397_hematopoietic_system_phenotyp | 0.93310304 |
105 | MP0001881_abnormal_mammary_gland | 0.92022921 |
106 | MP0005409_darkened_coat_color | 0.90220660 |
107 | MP0003183_abnormal_peptide_metabolism | 0.89306064 |
108 | MP0008260_abnormal_autophagy | 0.88803331 |
109 | MP0001663_abnormal_digestive_system | 0.87852472 |
110 | MP0000598_abnormal_liver_morphology | 0.87565272 |
111 | MP0002398_abnormal_bone_marrow | 0.87373282 |
112 | MP0008438_abnormal_cutaneous_collagen | 0.87025889 |
113 | MP0006054_spinal_hemorrhage | 0.86042191 |
114 | MP0010234_abnormal_vibrissa_follicle | 0.85895942 |
115 | MP0002009_preneoplasia | 0.85578981 |
116 | MP0005166_decreased_susceptibility_to | 0.84296923 |
117 | MP0002998_abnormal_bone_remodeling | 0.83886254 |
118 | MP0003075_altered_response_to | 0.83690574 |
119 | MP0002971_abnormal_brown_adipose | 0.82945052 |
120 | MP0002277_abnormal_respiratory_mucosa | 0.82306228 |
121 | MP0002429_abnormal_blood_cell | 0.81967643 |
122 | MP0002693_abnormal_pancreas_physiology | 0.80021548 |
123 | MP0005666_abnormal_adipose_tissue | 0.79741976 |
124 | MP0001764_abnormal_homeostasis | 0.79163952 |
125 | MP0004084_abnormal_cardiac_muscle | 0.78645690 |
126 | MP0000689_abnormal_spleen_morphology | 0.77585889 |
127 | MP0008874_decreased_physiological_sensi | 0.77221990 |
128 | MP0002933_joint_inflammation | 0.76965950 |
129 | MP0005376_homeostasis/metabolism_phenot | 0.76405662 |
130 | MP0005023_abnormal_wound_healing | 0.75938793 |
131 | MP0005621_abnormal_cell_physiology | 0.75049545 |
132 | MP0003787_abnormal_imprinting | 0.74440645 |
133 | MP0002132_abnormal_respiratory_system | 0.72816268 |
134 | MP0002136_abnormal_kidney_physiology | 0.71039891 |
135 | MP0004264_abnormal_extraembryonic_tissu | 0.69485714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.41045773 |
2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.32944732 |
3 | Prolonged bleeding time (HP:0003010) | 5.01282290 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.90991733 |
5 | Recurrent abscess formation (HP:0002722) | 4.46634015 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.41570799 |
7 | Increased mean platelet volume (HP:0011877) | 4.07346209 |
8 | Abnormal platelet volume (HP:0011876) | 4.00903950 |
9 | Epistaxis (HP:0000421) | 4.00568063 |
10 | T lymphocytopenia (HP:0005403) | 3.84674940 |
11 | Myocardial infarction (HP:0001658) | 3.72459080 |
12 | Abnormality of T cell number (HP:0011839) | 3.67392057 |
13 | Acanthocytosis (HP:0001927) | 3.64993687 |
14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.56053475 |
15 | Menorrhagia (HP:0000132) | 3.51458194 |
16 | Hypochromic microcytic anemia (HP:0004840) | 3.47227652 |
17 | Petechiae (HP:0000967) | 3.45747227 |
18 | Abnormality of macrophages (HP:0004311) | 3.44324880 |
19 | Papillary thyroid carcinoma (HP:0002895) | 3.18708204 |
20 | Microcytic anemia (HP:0001935) | 3.15151340 |
21 | Autoimmune thrombocytopenia (HP:0001973) | 3.01722001 |
22 | Orchitis (HP:0100796) | 3.01642329 |
23 | Tetraparesis (HP:0002273) | 2.95370917 |
24 | Systemic lupus erythematosus (HP:0002725) | 2.93856115 |
25 | Myositis (HP:0100614) | 2.92632588 |
26 | Gingivitis (HP:0000230) | 2.88756480 |
27 | Vacuolated lymphocytes (HP:0001922) | 2.88733013 |
28 | Conjunctival telangiectasia (HP:0000524) | 2.84280717 |
29 | Xanthomatosis (HP:0000991) | 2.78551778 |
30 | Leukocytosis (HP:0001974) | 2.76380494 |
31 | Slow saccadic eye movements (HP:0000514) | 2.74799070 |
32 | Joint hemorrhage (HP:0005261) | 2.73568933 |
33 | Increased cerebral lipofuscin (HP:0011813) | 2.73269982 |
34 | Hydroxyprolinuria (HP:0003080) | 2.70289768 |
35 | Abnormality of proline metabolism (HP:0010907) | 2.70289768 |
36 | Recurrent fungal infections (HP:0002841) | 2.69838075 |
37 | Recurrent skin infections (HP:0001581) | 2.69510346 |
38 | Esophageal varix (HP:0002040) | 2.69465177 |
39 | Intrahepatic cholestasis (HP:0001406) | 2.69410421 |
40 | Hematochezia (HP:0002573) | 2.67502063 |
41 | Retrobulbar optic neuritis (HP:0100654) | 2.65720650 |
42 | Optic neuritis (HP:0100653) | 2.65720650 |
43 | Pustule (HP:0200039) | 2.63937288 |
44 | Deep venous thrombosis (HP:0002625) | 2.62189841 |
45 | Purpura (HP:0000979) | 2.61437019 |
46 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.61338347 |
47 | Impaired platelet aggregation (HP:0003540) | 2.59889308 |
48 | Abnormal platelet function (HP:0011869) | 2.59889308 |
49 | Complement deficiency (HP:0004431) | 2.58519421 |
50 | Hypoalphalipoproteinemia (HP:0003233) | 2.57185312 |
51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52078692 |
52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51546101 |
53 | Mediastinal lymphadenopathy (HP:0100721) | 2.51389718 |
54 | Abnormality of the common coagulation pathway (HP:0010990) | 2.50337211 |
55 | Spontaneous hematomas (HP:0007420) | 2.50326773 |
56 | Polycythemia (HP:0001901) | 2.50071757 |
57 | Urticaria (HP:0001025) | 2.49804996 |
58 | Chest pain (HP:0100749) | 2.47296630 |
59 | Gingival bleeding (HP:0000225) | 2.47265301 |
60 | Arterial thrombosis (HP:0004420) | 2.45744325 |
61 | Hypoglycemic coma (HP:0001325) | 2.44733724 |
62 | Autoimmune hemolytic anemia (HP:0001890) | 2.40436179 |
63 | Abnormality of T cells (HP:0002843) | 2.39104910 |
64 | Subacute progressive viral hepatitis (HP:0006572) | 2.34088698 |
65 | Eosinophilia (HP:0001880) | 2.33542801 |
66 | Postural instability (HP:0002172) | 2.32268630 |
67 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32121053 |
68 | Osteolytic defects of the hand bones (HP:0009699) | 2.31193782 |
69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31193782 |
70 | Abnormality of complement system (HP:0005339) | 2.30448092 |
71 | Chronic diarrhea (HP:0002028) | 2.29077060 |
72 | Encephalitis (HP:0002383) | 2.26599735 |
73 | Hypochromic anemia (HP:0001931) | 2.25185814 |
74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23160070 |
75 | Osteomyelitis (HP:0002754) | 2.23091775 |
76 | Abnormality of the intrinsic pathway (HP:0010989) | 2.22320422 |
77 | Interstitial pulmonary disease (HP:0006530) | 2.19760812 |
78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19434957 |
79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19434957 |
80 | Granulocytopenia (HP:0001913) | 2.19402621 |
81 | Ulnar deviation of the wrist (HP:0003049) | 2.18751978 |
82 | Muscle fiber inclusion bodies (HP:0100299) | 2.17631381 |
83 | Fatigue (HP:0012378) | 2.17528313 |
84 | Periodontitis (HP:0000704) | 2.16960705 |
85 | Glomerulonephritis (HP:0000099) | 2.15503007 |
86 | Obstructive lung disease (HP:0006536) | 2.15333695 |
87 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15333695 |
88 | Cholelithiasis (HP:0001081) | 2.15175850 |
89 | Nausea (HP:0002018) | 2.14669844 |
90 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.13288288 |
91 | Abnormality of purine metabolism (HP:0004352) | 2.10233826 |
92 | Meningitis (HP:0001287) | 2.10113398 |
93 | Hypolipoproteinemia (HP:0010981) | 2.09718914 |
94 | Gastrointestinal infarctions (HP:0005244) | 2.09094178 |
95 | Hyperglycemia (HP:0003074) | 2.07851525 |
96 | Prostate neoplasm (HP:0100787) | 2.07527000 |
97 | Abnormality of iron homeostasis (HP:0011031) | 2.06794441 |
98 | Vasculitis (HP:0002633) | 2.06703919 |
99 | Thyroid carcinoma (HP:0002890) | 2.05765838 |
100 | Nemaline bodies (HP:0003798) | 2.05761623 |
101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04448021 |
102 | Mucopolysacchariduria (HP:0008155) | 2.04448021 |
103 | Recurrent viral infections (HP:0004429) | 2.03950287 |
104 | Myopathic facies (HP:0002058) | 2.03946424 |
105 | Orthostatic hypotension (HP:0001278) | 2.03638883 |
106 | Inflammation of the large intestine (HP:0002037) | 2.03497182 |
107 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02636588 |
108 | Dysostosis multiplex (HP:0000943) | 2.01951065 |
109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01144378 |
110 | Thrombophlebitis (HP:0004418) | 2.00912879 |
111 | Thick nail (HP:0001805) | 1.99040541 |
112 | Prolonged partial thromboplastin time (HP:0003645) | 1.98502450 |
113 | Axonal loss (HP:0003447) | 1.97400143 |
114 | Abnormality of the fingertips (HP:0001211) | 1.97253889 |
115 | Paralysis (HP:0003470) | 1.96641320 |
116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96321362 |
117 | Hyperlipoproteinemia (HP:0010980) | 1.95678182 |
118 | Fat malabsorption (HP:0002630) | 1.93964305 |
119 | Abnormality of eosinophils (HP:0001879) | 1.93721889 |
120 | Abnormal gallbladder morphology (HP:0012437) | 1.93183206 |
121 | Epidermoid cyst (HP:0200040) | 1.92531207 |
122 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92068423 |
123 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91227840 |
124 | Visual hallucinations (HP:0002367) | 1.90977649 |
125 | Anorexia (HP:0002039) | 1.90946097 |
126 | Viral hepatitis (HP:0006562) | 1.90079773 |
127 | Acute hepatic failure (HP:0006554) | 1.89157748 |
128 | Progressive visual loss (HP:0000529) | 1.88960270 |
129 | Bruising susceptibility (HP:0000978) | 1.88565059 |
130 | Hemoptysis (HP:0002105) | 1.88244080 |
131 | Hemorrhage of the eye (HP:0011885) | 1.87865685 |
132 | Stomatitis (HP:0010280) | 1.87581508 |
133 | Increased serum ferritin (HP:0003281) | 1.87094031 |
134 | Pulmonary embolism (HP:0002204) | 1.86871566 |
135 | Poikilocytosis (HP:0004447) | 1.86569728 |
136 | Recurrent bronchitis (HP:0002837) | 1.86047688 |
137 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85382114 |
138 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85382114 |
139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85382114 |
140 | Keratoconjunctivitis sicca (HP:0001097) | 1.85258611 |
141 | Cellulitis (HP:0100658) | 1.84594491 |
142 | Episodic fever (HP:0001954) | 1.84129704 |
143 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.83938881 |
144 | Joint swelling (HP:0001386) | 1.83202442 |
145 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83025837 |
146 | Pulmonary infiltrates (HP:0002113) | 1.82808672 |
147 | Peritonitis (HP:0002586) | 1.82660936 |
148 | Keratoconjunctivitis (HP:0001096) | 1.82617737 |
149 | Malnutrition (HP:0004395) | 1.82471254 |
150 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.81631384 |
151 | Nephritis (HP:0000123) | 1.81487358 |
152 | Upper motor neuron abnormality (HP:0002127) | 1.80000928 |
153 | Global brain atrophy (HP:0002283) | 1.79602093 |
154 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.78935643 |
155 | Cerebral inclusion bodies (HP:0100314) | 1.77609847 |
156 | Hyperkalemia (HP:0002153) | 1.77498947 |
157 | Gastrointestinal inflammation (HP:0004386) | 1.76899547 |
158 | Verrucae (HP:0200043) | 1.74646158 |
159 | Papilloma (HP:0012740) | 1.74646158 |
160 | Increased IgM level (HP:0003496) | 1.72186318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.37113143 |
2 | ERN1 | 3.00420178 |
3 | GRK6 | 2.77243200 |
4 | TYK2 | 2.73759340 |
5 | TBK1 | 2.69880075 |
6 | TAOK3 | 2.59533750 |
7 | IRAK4 | 2.39128257 |
8 | BMPR2 | 2.34794626 |
9 | FGFR4 | 2.29879659 |
10 | JAK3 | 2.22852998 |
11 | NEK9 | 2.21327115 |
12 | TRIB3 | 2.09319483 |
13 | BLK | 2.08600325 |
14 | IRAK3 | 2.03907085 |
15 | MST1R | 2.01075921 |
16 | PTK2B | 1.99732710 |
17 | JAK1 | 1.94814317 |
18 | EPHB1 | 1.88694621 |
19 | EPHA3 | 1.83323064 |
20 | CSK | 1.82645420 |
21 | PRPF4B | 1.75929171 |
22 | TTN | 1.73976977 |
23 | IKBKE | 1.73794193 |
24 | SGK2 | 1.73771686 |
25 | MAP3K2 | 1.64781315 |
26 | IKBKB | 1.63037019 |
27 | BCKDK | 1.57172534 |
28 | MAP3K3 | 1.55701446 |
29 | TAOK1 | 1.54315623 |
30 | PIK3CG | 1.47590804 |
31 | SGK3 | 1.46905798 |
32 | MAP2K3 | 1.45466417 |
33 | STK3 | 1.42514234 |
34 | GRK5 | 1.42214745 |
35 | PLK2 | 1.41670586 |
36 | MAP4K1 | 1.41340317 |
37 | ZAP70 | 1.41223415 |
38 | WNK1 | 1.41209935 |
39 | JAK2 | 1.40282589 |
40 | LATS1 | 1.38053657 |
41 | FRK | 1.36031660 |
42 | PKN2 | 1.35145972 |
43 | PTK6 | 1.34095924 |
44 | PIM1 | 1.31758732 |
45 | STK10 | 1.31547461 |
46 | RIPK4 | 1.31307146 |
47 | CHUK | 1.29711096 |
48 | FES | 1.25647071 |
49 | MAP3K1 | 1.25219717 |
50 | FGFR3 | 1.25089610 |
51 | RIPK1 | 1.20305573 |
52 | MST4 | 1.18526009 |
53 | PIM2 | 1.18180409 |
54 | PBK | 1.14042812 |
55 | KSR1 | 1.13535635 |
56 | EPHA2 | 1.13050442 |
57 | YES1 | 1.12866133 |
58 | ERBB2 | 1.10484200 |
59 | TAOK2 | 1.10423660 |
60 | MAP3K13 | 1.08099466 |
61 | IRAK2 | 1.06982343 |
62 | INSRR | 1.05537012 |
63 | ITK | 1.01134307 |
64 | SIK3 | 1.00980423 |
65 | SGK494 | 1.00043545 |
66 | SGK223 | 1.00043545 |
67 | MATK | 0.99858510 |
68 | MARK3 | 0.98695167 |
69 | FLT3 | 0.96420691 |
70 | TGFBR2 | 0.93336782 |
71 | BTK | 0.93257426 |
72 | CDK6 | 0.92253234 |
73 | HCK | 0.92252307 |
74 | RPS6KA4 | 0.89659783 |
75 | CAMKK2 | 0.88235379 |
76 | MAP3K6 | 0.87614167 |
77 | KSR2 | 0.87105610 |
78 | TXK | 0.86738889 |
79 | TEC | 0.85391898 |
80 | MAP3K11 | 0.85156317 |
81 | MAP3K5 | 0.84815864 |
82 | PDK2 | 0.81729977 |
83 | NME2 | 0.80936928 |
84 | DYRK1B | 0.80923204 |
85 | MARK2 | 0.79591020 |
86 | TRPM7 | 0.77836056 |
87 | PIK3CA | 0.76851591 |
88 | TESK1 | 0.75953617 |
89 | STK4 | 0.75355721 |
90 | ERBB4 | 0.73987250 |
91 | PDK4 | 0.73314655 |
92 | PDK3 | 0.73314655 |
93 | SIK1 | 0.73294888 |
94 | KIT | 0.73293076 |
95 | ABL2 | 0.73131217 |
96 | DYRK1A | 0.72470131 |
97 | MET | 0.71967697 |
98 | CAMK1D | 0.71102744 |
99 | MAPK11 | 0.68647055 |
100 | ACVR1B | 0.67416926 |
101 | OBSCN | 0.67401947 |
102 | FGR | 0.66666338 |
103 | IRAK1 | 0.64842646 |
104 | CSF1R | 0.64152097 |
105 | EIF2AK1 | 0.64049290 |
106 | NUAK1 | 0.63633461 |
107 | MAP3K8 | 0.63588751 |
108 | ZAK | 0.63139978 |
109 | CDK9 | 0.61186294 |
110 | DYRK3 | 0.61176222 |
111 | SYK | 0.59359131 |
112 | EGFR | 0.58866161 |
113 | LCK | 0.56999170 |
114 | NEK2 | 0.56487393 |
115 | PTK2 | 0.55505322 |
116 | ABL1 | 0.55500180 |
117 | AKT3 | 0.54626497 |
118 | RET | 0.53468118 |
119 | LRRK2 | 0.53353361 |
120 | LYN | 0.49782552 |
121 | BMX | 0.48489157 |
122 | SGK1 | 0.48127745 |
123 | STK24 | 0.47211394 |
124 | PDPK1 | 0.46999694 |
125 | HIPK2 | 0.45084206 |
126 | MAP2K6 | 0.44546215 |
127 | PDK1 | 0.44529190 |
128 | CDK12 | 0.44116762 |
129 | PRKAA2 | 0.43891642 |
130 | KDR | 0.43636781 |
131 | STK38 | 0.43167294 |
132 | MAP2K2 | 0.43035435 |
133 | NLK | 0.42457041 |
134 | RAF1 | 0.42029098 |
135 | PDGFRB | 0.41854663 |
136 | PRKAA1 | 0.41753611 |
137 | ERBB3 | 0.41001713 |
138 | MAP3K7 | 0.39561821 |
139 | MAPK12 | 0.38576991 |
140 | PRKCQ | 0.34471487 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.98618634 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.28141673 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.24304302 |
4 | Platelet activation_Homo sapiens_hsa04611 | 2.00499043 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96731840 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90315437 |
7 | Legionellosis_Homo sapiens_hsa05134 | 1.89521487 |
8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.77506471 |
9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.76348558 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71728536 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67777379 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61492770 |
13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60294807 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59251545 |
15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57376582 |
16 | Lysosome_Homo sapiens_hsa04142 | 1.56349413 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55581662 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.51317399 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50039437 |
20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.43821669 |
21 | Malaria_Homo sapiens_hsa05144 | 1.42483690 |
22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39943065 |
23 | Measles_Homo sapiens_hsa05162 | 1.39418121 |
24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36081756 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33971569 |
26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32983474 |
27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32783396 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.31843420 |
29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31603427 |
30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31020570 |
31 | Allograft rejection_Homo sapiens_hsa05330 | 1.29497169 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28925290 |
33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28856024 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.25584389 |
35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25480948 |
36 | Pertussis_Homo sapiens_hsa05133 | 1.23874961 |
37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23127399 |
38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22977809 |
39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20181854 |
40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18994114 |
41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16499456 |
42 | Apoptosis_Homo sapiens_hsa04210 | 1.15851107 |
43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12674830 |
44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12141739 |
45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09102754 |
46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08895342 |
47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08472720 |
48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.08314697 |
49 | ABC transporters_Homo sapiens_hsa02010 | 1.07259464 |
50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07071533 |
51 | Insulin resistance_Homo sapiens_hsa04931 | 1.06789886 |
52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06621082 |
53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05991498 |
54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05776321 |
55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03735661 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02979690 |
57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02619581 |
58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01373884 |
59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00972250 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00562591 |
61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98319703 |
62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95700820 |
63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94189645 |
64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94082354 |
65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93841140 |
66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92348382 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92000392 |
68 | Phagosome_Homo sapiens_hsa04145 | 0.91455738 |
69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89619205 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.88877707 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87825591 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87127713 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86903405 |
74 | Asthma_Homo sapiens_hsa05310 | 0.83417603 |
75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83338137 |
76 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82600535 |
77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81500403 |
78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81378636 |
79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81284751 |
80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80893920 |
81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79377766 |
82 | Peroxisome_Homo sapiens_hsa04146 | 0.78842957 |
83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78822305 |
84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78074820 |
85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77288190 |
86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76998029 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76170167 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74052486 |
89 | Shigellosis_Homo sapiens_hsa05131 | 0.73089379 |
90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73022202 |
91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71404061 |
92 | Salmonella infection_Homo sapiens_hsa05132 | 0.71234755 |
93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69896612 |
94 | Hepatitis B_Homo sapiens_hsa05161 | 0.69363739 |
95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68371613 |
96 | Prostate cancer_Homo sapiens_hsa05215 | 0.67830644 |
97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67618345 |
98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67514631 |
99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67227380 |
100 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66598406 |
101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66536030 |
102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66465608 |
103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66368906 |
104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65782338 |
105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65204774 |
106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65130631 |
107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65040295 |
108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64496415 |
109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64041029 |
110 | Amoebiasis_Homo sapiens_hsa05146 | 0.63631049 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63280163 |
112 | Endocytosis_Homo sapiens_hsa04144 | 0.62361145 |
113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61227731 |
114 | Glioma_Homo sapiens_hsa05214 | 0.60777203 |
115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59297944 |
116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58559111 |
117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58546272 |
118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58494536 |
119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56971687 |
120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56306201 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56004537 |
122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55976944 |
123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55462415 |
124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55093840 |
125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55009350 |
126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55000099 |
127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54882147 |
128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54543040 |
129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54080592 |
130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53933891 |
131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53346954 |
132 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52659870 |
133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51915557 |
134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51287196 |
135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50423290 |
136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50081931 |
137 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49708793 |
138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49536078 |
139 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48654833 |
140 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47925386 |
141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47884401 |
142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47184353 |
143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46869218 |
144 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46153178 |